We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

127 hedge funds and large institutions have $211M invested in Tvardi Therapeutics in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

5% more funds holding

Funds holding: 121 → 127 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.16% less ownership

Funds ownership: 1.63% → 1.47% (-0.16%)

19% less capital invested

Capital invested by funds: $262M → $211M (-$50.5M)

28% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 39

30% less call options, than puts

Call options by funds: $4.36M | Put options by funds: $6.24M

Holders
127
Holders Change
+6
Holders Change %
+4.96%
% of All Funds
2.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
28
Reduced
39
Closed
21
Calls
$4.36M
Puts
$6.24M
Net Calls
-$1.88M
Net Calls Change
+$2.45M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.69M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.42M
3
EMG
ETF Managers Group
New Jersey
+$1.61M
4
First Manhattan
First Manhattan
New York
+$1.29M
5
Millennium Management
Millennium Management
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$20.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.61M
3
Invesco
Invesco
Georgia
-$3.19M
4
ARTA
A.R.T. Advisors
New York
-$2.2M
5
UBS AM
UBS AM
Illinois
-$1.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$909K +$229K +502 +32%
Deutsche Bank
27
Deutsche Bank
Germany
$908K -$944K -2,071 -50%
TCIM
28
TIAA CREF Investment Management
New York
$781K -$1.05M -2,301 -56%
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$777K – – –
CS
30
Credit Suisse
Switzerland
$763K +$155K +341 +25%
TAM
31
Tiverton Asset Management
Delaware
$721K -$440K -966 -37%
Janney Montgomery Scott
32
Janney Montgomery Scott
Pennsylvania
$701K +$455K +998 +168%
BCM
33
Bridgeway Capital Management
Texas
$673K – – –
SAMH
34
Shanda Asset Management Holdings
British Virgin Islands
$673K +$696K +1,527 New
Charles Schwab
35
Charles Schwab
California
$666K +$192K +422 +39%
TA
36
Teachers Advisors
New York
$617K – – –
OAM
37
Oxford Asset Management
United Kingdom
$561K +$557K +1,222 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$518K – – –
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$516K -$15K -33 -3%
Federated Hermes
40
Federated Hermes
Pennsylvania
$478K -$8.21K -18 -2%
Stifel Financial
41
Stifel Financial
Missouri
$476K -$321K -704 -39%
UBS Group
42
UBS Group
Switzerland
$475K -$914K -2,004 -65%
AllianceBernstein
43
AllianceBernstein
Tennessee
$472K – – –
PPA
44
Parametric Portfolio Associates
Washington
$443K +$34.2K +75 +8%
AQR Capital Management
45
AQR Capital Management
Connecticut
$383K -$155K -340 -28%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$368K – – –
VEA
47
Virtus ETF Advisers
New York
$338K +$111K +243 +46%
VFA
48
Virtus Fund Advisers
Connecticut
$338K +$350K +768 New
SKK
49
Shepherd Kaplan Krochuk
Massachusetts
$324K -$335K -735 -50%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$320K -$62K -136 -16%
1
2
3 4 5

TVRD Hedge Fund Activity: Q4 2017 in Review

127 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q4 2017, worth a combined $211M — down 19% from $262M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TVRD positions and 21 closed out — a net gain of 6 holders — while 28 added to existing stakes and 39 trimmed.

The largest buyer was BlackRock, adding an estimated $5.69M. The largest seller was State Street, cutting an estimated $20.7M.

  • 127 institutional investors held Tvardi Therapeutics (TVRD) as of Q4 2017, up from 121 in Q3 2017.
  • Funds reported $211M of Tvardi Therapeutics stock for Q4 2017, down 19% quarter-over-quarter.
  • 27 funds opened new Tvardi Therapeutics positions in Q4 2017 and 21 closed out, a net change of +6 holders.
  • The largest Tvardi Therapeutics buyer in Q4 2017 was BlackRock, an estimated $5.69M added.
  • The largest Tvardi Therapeutics seller in Q4 2017 was State Street, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2017.